Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Zerodha CASE Nifty Midcap 150 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Zerodha | Nippon India |
| NAV | ₹11.4101 | ₹29.1708 |
| NAV date | 19 Nov 2026 | 19 Nov 2026 |
| History | 2.4 years | 5.4 years |
| Expense ratio | 0.2% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Zerodha CASE Nifty Midcap 150 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +5.34% | +10.76% |
| 3 months | −2.74% | +7.79% |
| 6 months | +1.73% | +14.37% |
| YTD | +2.63% | +25.34% |
| 1 year | +2.06% | +25.28% |
| 3 years (CAGR) | — | +21.97% |
| 5 years (CAGR) | — | +16.60% |
| 10 years (CAGR) | — | — |
| Since launch | +4.57% | +14.02% |
Risk
| Zerodha CASE Nifty Midcap 150 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | — | 15.0% |
| Downside volatility | — | 9.0% |
| Sharpe | — | 1.03 |
| Sortino | — | 1.71 |
| Calmar | — | 1.33 |
| Return / risk | — | 1.47 |
| Deepest fall | −20.81% | −20.98% |
| Days to recover | 257 | 136 |
| Below its high | −3.75% | −1.80% |
Against benchmark
| Zerodha CASE Nifty Midcap 150 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | — | −0.00% |
| Beta | — | 1.00 |
| R² | — | 100.0% |
| Up capture | — | 100.0% |
| Down capture | — | 100.0% |
| Tracking error | — | 0.0% |
| Information ratio | — | — |
| Treynor | — | 0.14 |
Consistency
| Zerodha CASE Nifty Midcap 150 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | +22.29% | +65.21% |
| Middle 1-year | +6.15% | +13.45% |
| Worst 1-year | −5.36% | −15.30% |
| 1-year periods with a loss | 13.4% | 25.8% |
| Middle 3-year | — | +20.51% |
| Positive months | — | 61.1% |
| Best day | +3.97% | +3.64% |
| Worst day | −3.92% | −4.03% |
| Worst 5% day | −2.04% | −1.62% |
| Positive days | 55.2% | 54.4% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Zerodha CASE Nifty Midcap 150 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | — | +20.60% |
| 5-year value | — | ₹10,11,201 |
| 3-year XIRR | — | +19.58% |
| 1-year XIRR | +5.72% | +34.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.